Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead
DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTIONToronto, Ontario--(Newsfile Corp. - April 27, 2021) -...
pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026